Biologics are a wide range of substances synthesized by cells or living organisms.
A biosimilar is a copy of an authorized original biological medicinal product.
Safety and efficacy of biosimilars are comparable to the originator's.
The post-marketing safety evaluation is stringent as for any new biological product.